KLRK1 and neoplasm: Vγ9Vδ2 T cells generally recognize tumor target cells either through the TCR or through stimulatory NK receptors, such as NKG2D and DNAX accessory molecule 1 (DNAM-1), that recognize their specific ligands overexpressed on tumor cells.